Set-Curato Speaks to the Molecule: Unfolding Therapeutization at Biomarkers International Conference

Treatment efficacy for diseases and disorders prioritize the prognosis and diagnosis accuracy; molecular marking being the next step. OMICS Group International is pleased to announce the 6th International Conference on Biomarkers & Clinical Research during August 31 to September 02, 2015 in Toronto, Canada with a view to promote the current research from lab to industry as bio signatures to therapeutic discoveries, to meet the challenges of next generation.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend

Biomarkers-2014

Biomarkers-2015: Obsessed with disorders now trace the treatment

Henderson, NV (PRWEB) June 12, 2014

Dr. Leticia Cano, Biomarkers Profile Cooperation, USA; Prof. Sergey Suchkov, EPMA, EU; Dr. Pavel Vodicka, Institute of Experimental Medicine, Czech Rep. and Dr. Gabriella Baio, University of Aberdeen, UK, are few of the Organizing Committee Members adding value to this Scientific Meeting.

Biomarkers-2015 highlights Cancer Biomarkers; Blood Biomarkers; Genomics and Proteomics; Cytogenetic and Molecular Imaging Biomarkers; Analytical Biomarkers; Biomarkers in Clinical Research and Development; Biomarkers for Disorders; Techniques to Maximize Biomarker Identification; Omics Technologies in Biomarkers Discovery and Validation; Biomarkers and Nanoparticles.

Scientific eminents who are going to mark their presence in this pragmatic International Clinical Conference includes Prof. Sidney Kennedy, University of Toronto, Canada; Alex Buko, Human Metabolome Technologies America, Inc, USA; Chee Gee See, Director of Personalised Medicine at Proteome Sciences plc, UK; Virginia Litwin, Principal Scientist at Covance Central Laboratory Services, USA; Yongmei Li, Vice President, Sino-American Pharmaceutical Professionals Association (SAPA), USA; Martin Beaulieu, Director MicroMarkers at Regulus Therapeutics, USA; Eduard Rogatsky, Albert Einstein College of Medicine, USA; Anna Langerveld, President & CEO at Genemarkers LLC, USA; Bruce Davis, President and CEO, Trillium Diagnostics, USA; Bruce Sodowich, BioArray Solutions, an Immucor Company, USA; Prof. Dave S. B. Hoon, Director, John Wayne Cancer Institute, USA; Shashwati Basak, Biocon Bristol-Myers Squibb Research Center, India; Dragana Pilavdzic, University Health Networks Toronto, Canada and Commes Therese, CHRU Hopital Saint Eloi, France.

A global workshop on Personalized Medicine Focusing PPPM-related generations of drugs as applicable to Drug Discovery and Drug Design supported from the PPPM representatives around the globe is in the conversation. Workshop featuring Biomarkers for Mass Spectroscopy to be conducted, in support with Dr. Leticia Cano. And a special session featuring Women in Biomarkers, the one of its kind will be one among other highlights at the Biomarkers-2015.

OMICS Publishing Group publishes 350 online open access journals in clinical, medical, life sciences, including management, engineering, technology, and pharmaceutical fields with an aim to provide healthcare information free from the copyright barriers by organizing over 150 International Scientific Meetings across the globe annually. OMICS Group enjoys the support of a strong 30,000 members in the editorial team with a readership of 3.5 million. OMICS Group has collaborated with more than 100 scientific associations and institutions worldwide to promote information on healthcare through ‘Open Access’ platform.

OMICS Publishing Group International Scientific Conferences facilitates the young researchers and scholars to interact with the world class experts in respective fields to evaluate their research through its Young Research Forum, Best Poster Award Competition and Student Fellowship., thus encouraging student participation in the scientific research and development.

We invite eminent in the research arena of Biomarkers to participate as speakers, delegates and also to conduct International Workshops on related scientific sessions of the conference. Biomarkers-2015 edges out the aspects of setting up a successful B2B environment to foster fruitful healthcare ventures.

For more details and for further information related to Biomarker-2015, please contact:

Michael Smith
Biomarkers-2015
Clinical Conferences
2360 Corporate Circle Suite,
400 Henderson, NV 89074-7722,
USA
Office Ph: +1-888-843-8169 F: +1-650-618-1414
Email: biomarkers2015(at)omicsgroup(dot)us


Contact

Follow us on: Contact's Google Plus

Attachments